Plain-English translation of NCT06662448 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called repetitive transorbital alternating current stimulation (rtACS), which uses gentle electrical current applied near your eyes to help improve vision. The treatment is designed for people who have optic neuropathy—a condition where the nerve connecting the eye to the brain is damaged, causing vision loss. Researchers want to see if doing this treatment at home can help slow or reverse vision problems and make it easier for you to do daily activities.
Optic neuropathy often causes progressive vision loss that affects a person's independence and quality of life, and there are limited treatment options available. This study is testing whether electrical stimulation might be a safe and effective way to help restore vision and functional ability in people living with this condition.
You likely qualify if…
You likely don't qualify if…
You'll have 30 stimulation sessions over 8 weeks. The first two sessions happen in the office—one the day after your baseline visit, and another 48 hours later. Then you'll do 28 sessions at home every other day for the remaining 8 weeks. Each session involves applying electrical stimulation near your eyes using a device. You'll also attend a baseline visit, a visit right after treatment ends, and two follow-up visits to check how you're doing and measure any changes in your vision and daily functioning.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States